MAPT and Alzheimer disease: Genetically or pharmacologically, the reduction of senescent cells improves Aβ peptide and tau protein-induced neuropathology and improves memory in AD model mice (Bussian et al., 2018; Zhang et al., 2019), thus achieving a counteracting effect on cognitive impairment (Hou et al., 2019).